Cell interactions control the fate of malignant keratinocytes in an organotypic model of early neoplasia

Journal of Investigative Dermatology

Volumn 113, Issue 3, 1999, Pages 384-391

  Vaccariello, Michael ^a   Javaherian, Ashkan ^a   Wang, Youai ^a   Fusenig, Norbert E ^c   Garlick, Jonathan A ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Intraepithelial neoplasia; Organotypic culture; Tumor suppression

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL INTERACTION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER;

EID: 0032885341     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00701.x     Document Type: Article

References (52)

1. Bauer G: Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol Histopathol 11:237-255, 1996
2. Berwald Y, Sachs L: In vitro cell transformation with chemical carcinogens. Nature 200:1182-1184, 1963
3. Boukamp P, Stanbridge EJ, Yin-Foo D, Cerutti PA, Fusenig NE: c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Caner Res 50:2840-2847, 1990
4. H oncogene activation and additional chromosome loss. Oncogene 11:961-969, 1995
5. Brash DE: Sunlight and the onset of skin cancer. Trends Genet 13:410-414, 1997
6. Brash DE, Rudolph JA, Simon JA, et al: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991
7. Brash DE, Ziegler A, Jonasson AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1:136-142, 1996
8. Breitkreutz D, Schoop VM, Mirancea N, Baur M, Stark H-J, Fusenig NE: Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Bio 75:273-286, 1998
9. Dotto GP, Parada LF, Weinberg RA: Specific growth response of ras-transformed embryo fibroblasts to tumor promoters. Nature 318:472-475, 1975
10. Dotto GP, Weinberg RA, Ariza A: Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. Proc Natl Acad Sci USA 85:6389-6393, 1988
11. Dotto GP, el-Fouly MH, Nelson C, Trosko JE: Similar and synergistic inhibition of gap-junctional communication by ras transformation and tumor promoter treatment of mouse primary keratinocytes. Oncogene 4:637-641, 1989
12. Dowling J, Yu Q-C, Fuchs E: β4 Integrin is required for hemidesmosomes formation, cell adhesion and cell survival. J Cell Biol 134:559-572, 1996
13. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993
14. Fitzgerald DJ, Yamasaki H: Tumor promotion: models and assay systems. Teratogenesis Carcinogenesis Mutagenesis 10:89-102, 1990
15. el-Fouly MH, Trosko JE, Chang CC, Warren ST: Potential role of the human Haras oncogene in the inhibition of gap junctional intercellular communication. Mol Carcinog 2:131-135, 1989
16. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-626, 1994
17. Garlick JA. Retroviral vectors, In: Leigh IM, Lane B, Watt FM (eds). Keratinocyte Methods. Cambridge: Cambridge University Press, 1994, pp 181-183
18. Gillett NA, Thomassen DG, Buchholz A, Kelly G: Cell-line-dependent inhibition of phenotypic expression of prencoplastic and neoplastic tracheal epithelial cells by normal tracheal cells in denuded tracheal transplants. Carcinogenesis 10:1147-1154, 1989
19. Hennings H, Robinson VA, Michael DM, Pettit GR, Jung R, Yuspa SH: Development of an in vitro analogue of initiated mouse epidermis to study promoters and antipromoters. Cancer Res 50:4794-4800, 1990
20. Hennings H, Lowry DT, Robinson VA: Coculture of neoplastic and normal keratinocytes as a model to study tumor promotion. Skin Pharmacol 4:79-84, 1991
21. Hennings H, Lowry DT, Robinson VA, Morgan DL, Fujiki H, Yuspa SH: Activity of diverse tumor promoters in a keratinocyte co-culture model of initiated epidermis. Mol Carcinog 13:2145-2151, 1992
22. Herschman HR, Brankow DW: Ultraviolet irradiation transforms C3H10T1/2 cells to a unique, suppressible phenotype. Science 234:1385-1388, 1986
23. Herschman HR, Brankow DW: Colony size, cell density and nature of the tumor promoter are critical variables in expression of a transformed phenotype (focus formation) in co-cultures of UV-TDTx and C3H10T1/2 cells. Carcinogenesis 8:993-998, 1987
24. Javaherian A, Vaccariello M, Fusenig NE, Garlick JA: Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. Cancer Res 58:2200-2209, 1998
25. Jonasson AS, Kunala S, Price GJ, et al: Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 93:14025-14029, 1996
26. Kalimi GH, Sirsat SM: The relevance of gap junctions to stage 1 minor promotion in mouse epidermis. Carcinogenesis 5:1671-1677, 1984
27. Karen JR, Wang Y, Javaherian A, Vaccariello M, Fusenig NE, Garlick JA: 12-O-Tetradecanoylphorhol-13-acetate induces clonal expansion of potentially malignant keratinocytes in a tissue model of early neoplastic progression. Cancer Res 59:474-481, 1999
28. Loewenstein WR: Junctional intercellular communication: the cell-to-cell membrane channel. Physiol Rev 61:829-913, 1981
29. Martin W, Zempel G, Hulser D, Willecke K: Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Cancer Res 51:5348-5351, 1991
30. McCall C, Cohen J: Programmed cell death in terminally differentiating keratinocytes. J Invest Dermatol 97:111-115, 1991
31. Mehta PP, Bertram JS, Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44:187-196, 1986
32. Parenteau NL. Skin equivalents. In: Leigh IM, Lane B, Watt FM:eds. The Keratinocyte Handbook Cambridge, Cambridge University Press, 1994:pp 45-56
33. Pignatelli M, Stamp G: Integrins in tumor development and spread. Cancer Surveys 24: 113-127, 1995
34. Potter VR: Phenotypic diversity in experimental hepatomas: The concept of partially blocked oncogeny. Br J Cancer 38:1-23, 1978
35. Potter VR: Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J Biol Med 53:367-384, 1980
36. Ramon Y Cajal S, Missero C, Marchetti E, Dotto GP: Dermal fibroblasts tumor suppression of ras-transformed keratinocytes is associated with induction of squamous cell differentiation. Am J Pathol 145:846-855, 1994
37. Read J, Watt FM: A model for in vitro studies of epidermal homeostasis: Proliferation and involucrin synthesis by cultured human keratinocytes during recovery after stripping off the suprabasal layers. J Invest Dermatol 90:739-743, 1988
38. Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinocyte colonies from single cells. Cell 6:331-344, 1975
39. Stoker MG, Shearer M, O'Neill C: Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1:297-310, 1966
40. Stoker M, O'Neill C, Berryman S, Waxman V: Anchorage and growth regulation in normal and virus-transformed cells. Int J Cancer 3:683-693, 1968
41. Strickland JE, Ueda M, Hennings H, Yuspa SH: A model for initiated mouse skin: suppression of papilloma but carcinoma formation by normal epidermal cells in grafts no athymic nude mice. Cancer Res 52:1439-1444, 1992
42. Terzaghi M, Nettesheim P, Williams ML: Repopulation of denuded tracheal grafts with normal, prencoplastic and neoplastic epithelial call populations. Cancer Res 38:4546-4553, 1978
43. Terzaghi-Howe M: Inhibition of carcinogen-altered rat tracheal epithelial cell proliferation by normal epithelial cells in vivo. Carcinogenesis 8:145-150, 1987
44. Terzaghi Howe M: Inhibitor production by normal rat tracheal epithelial cells influences the frequency of spontaneous and x-ray-induced enhanced growth variants. Carcinogenesis 10:967-971, 1989
45. Trosko JE: Cancer causation. Nature 290:356, 1981
46. Trosko JE, Chang CC, Medcalf A: Mechanisms of tumor promotion: potential role of intercellular communication. Cancer Invest 1:511-526, 1983
47. Vaccariello MA, Javaherian A, Parenteau N, Garlick JA. Use of skin equivalent technology in a wound healing model. In: Morgan JR, Yarmush MI. (eds). Tissue Engineering Methods and Protocols. Totowa, NJ: Humana Press, 1999, 391-405
48. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231-245, 1997
49. Wu Y-J, Parker LM, Binder NE, Beckett MA, Sinard JH, Griffiths CT, Reinwald JG: The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells nonkeratinizing epithelia. Cell 31:693-703, 1982
50. Yotti LP, Chang CC, Trosko JE: Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206:1089-1091, 1979
51. Yuspa SH: Chemical carcinogenesis related to the skin: Part 1. Prog Dermatol 15:1-10, 1981
52. Yuspa SH, Dlugosz AA, Cheng CK, Denning MF, Tennenbaum T, Glick AB, Weinberg WC: Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol 103:90S-95S, 1994